Document Detail


Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
MedLine Citation:
PMID:  19526307     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although rheumatoid arthritis (RA) and myositis are major autoimmune diseases, co-occurrence of the two is rare. We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide. Prednisolone (PSL) in combination with methotrexate (MTX) was effective in managing the PM, but the RA relapsed during the treatment. Based on the clinical course, we suspect that the PM was induced by the leflunomide treatment and suggest that clinicians should consider the possibility of this rare adverse event in cases of cholestyramine-resistant elevation of transaminases.
Authors:
Sae Ochi; Ken Taniguchi; Masakazu Nagashima
Related Documents :
8157207 - Relationship between autoantibody and dermatosis in myelodysplastic syndrome.
20857157 - Synovial fluid β-endorphin level in avascular necrosis, rheumatoid arthritis, and osteo...
9330247 - Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measurin...
23524657 - The ad-csf-index discriminates alzheimer's disease patients from healthy controls: a va...
25256447 - Early umbilical cord blood-derived stem cell transplantation does not prevent neurologi...
7060757 - A technique for the aspiration of oocytes from human ovarian follicles.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-06-13
Journal Detail:
Title:  Modern rheumatology / the Japan Rheumatism Association     Volume:  19     ISSN:  1439-7595     ISO Abbreviation:  Mod Rheumatol     Publication Date:  2009  
Date Detail:
Created Date:  2009-08-04     Completed Date:  2009-11-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100959226     Medline TA:  Mod Rheumatol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  443-6     Citation Subset:  IM    
Affiliation:
Department of Rheumatology, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kohtohbashi, Sumida-ku, Tokyo 130-8575, Japan. ochisae@bokutoh-hp.metro.tokyo.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / adverse effects*
Alanine Transaminase / blood
Anti-Inflammatory Agents / therapeutic use
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / complications,  drug therapy,  pathology*
Aspartate Aminotransferases / blood
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents / therapeutic use
Isoxazoles / adverse effects*
Methotrexate / therapeutic use
Middle Aged
Muscle, Skeletal / drug effects,  pathology
Polymyositis / chemically induced,  drug therapy,  pathology*
Prednisolone / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Anti-Inflammatory Agents; 0/Antirheumatic Agents; 0/Immunosuppressive Agents; 0/Isoxazoles; 50-24-8/Prednisolone; 59-05-2/Methotrexate; 75706-12-6/leflunomide; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.6.1.2/Alanine Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-l...
Next Document:  Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer p...